Latest market headlines for INDOCO on Terminal.
27-Oct-2026 15:40:28
• AnaCipher, Indoco Remedies' clinical research organisation, approved by Brazil's ANVISA for clinical and bioanalytical facilities • Inspection was conducted…
27-Oct-2026 12:49:34
REVENUE UP 7.32% AT ₹520.17 CR (YOY), UP 11.27% (QOQ) EBITDA UP 7.85% AT ₹46.43 CR (YOY), UP 13.19% (QOQ) MARGINS AT 8.93% VS 8.88% (YOY), 8.77% (QOQ)
28-Sept-2026 21:00:09
• Wholly owned subsidiary, "Warren Lifesciences Private Limited" (WLPL), incorporated on September 26, 2026. • WLPL has authorized share capital of ₹1,00,000 d…
18-Sept-2026 17:58:40
• Committee approved incorporation of wholly owned subsidiary "Warren Lifesciences Private Limited". • Name approval received from Registrar of Companies, Mumb…
10-Sept-2026 12:51:51
• UK MHRA inspected the company's manufacturing facility at Plant I (solid oral dosage form) in Goa from September 7 to September 9, 2026. • The inspection con…
05-Sept-2026 13:38:45
• The United States Food and Drug Administration (USFDA) inspected the company's manufacturing facility at Plant II (Sterile) located at Goa. • The inspection…
26-Jun-2026 12:21:45
• Malta Medicines Authority inspected the Company's manufacturing facility for solid oral dosage form (Plant I) located at Goa. • Inspection was conducted from…